(19)
(11) EP 4 824 090 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24846762.3

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07K 16/24(2006.01)
A61K 39/395(2006.01)
A61P 37/08(2006.01)
A61K 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/244; A61K 2039/505; A61K 2039/545; C07K 2317/24; C07K 2317/76; A61P 37/08; A61K 39/3955; A61K 31/58
 
C-Sets:
  1. A61K 39/3955, A61K 2300/00;
  2. A61K 31/58, A61K 2300/00;

(86) International application number:
PCT/US2024/060022
(87) International publication number:
WO 2025/128990 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610089 P
17.05.2024 US 202463648940 P

(71) Applicant: Dermira, Inc.
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • BIRT, Julie Alison
    Indianapolis, Indiana 46206-6288 (US)
  • DEARDORFF, Lynn Marie
    Indianapolis, Indiana 46206-6288 (US)
  • NATALIE, Chitra Rao
    Indianapolis, Indiana 46206-6288 (US)
  • PILLAI, Sreekumar Govinda
    Indianapolis, Indiana 46206-6288 (US)
  • RODRIGUEZ CAPRILES, Claudia Irene
    Indianapolis, Indiana 46206-6288 (US)

(74) Representative: Eli Lilly and Company Limited 
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU
Bracknell, Berkshire RG12 1PU (GB)

   


(54) IL-13 ANTIBODIES FOR THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS